Axel Bouchon, Ph.D., is a biochemist, author and serial entrepreneur in the biotech, consumer and technology industries and is focused on neuroscience and prevention of neurological diseases. He is fundamentally driven by the question “What makes our brains truly happy?”.
Axel joined ARCH as a Venture Partner in 2021. He is a Director at Brii Biosciences, Co-founder and Chairman of BrainLuxury, Inc., and Cofounder and CEO of BrainGames Corporation. Before joining ARCH, Axel was leading the venture activities of LEAPS by Bayer (2015-2019) and Moderna Therapeutics, Inc. (2013-2014), and served as CEO, director and chairman in multiple pharmaceutical and biotechnology companies over the last 15 years.
Axel holds a Ph.D. in biochemistry, organic chemistry and immunology from the University of Tuebingen, Germany.